Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-<italic style="font-style: italic">κ</italic>B/iNOS/NO Signaling Pathway

HU Jinping; CHEN Liyun; YAN Shiyun

doi:10.13422/j.cnki.syfjx.202202028

您当前的位置：

首页 >

文章列表页 >

Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-κB/iNOS/NO Signaling Pathway

更新时间：2023-01-03

- Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-κB/iNOS/NO Signaling Pathway
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 29, Issue 3, Pages: 110-116(2023)
- 作者机构：
  
  1.上海中医药大学科技人文研究院，上海 200001
  2.青海省中医院，西宁 810000
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.202202028
  CLC： R22;R242;R2-031;R287
- Received：07 May 2022，
  
  Published Online：18 August 2022，
  
  Published：05 February 2023
- 稿件说明：
移动端阅览
胡金萍,陈丽云,严世芸.基于NF-κB/iNOS/NO信号通路探讨生脉散加减对老年心肌梗死患者心功能的保护作用[J].中国实验方剂学杂志,2023,29(03):110-116.

HU Jinping,CHEN Liyun,YAN Shiyun.Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-κB/iNOS/NO Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(03):110-116.
胡金萍,陈丽云,严世芸.基于NF-κB/iNOS/NO信号通路探讨生脉散加减对老年心肌梗死患者心功能的保护作用[J].中国实验方剂学杂志,2023,29(03):110-116. DOI： 10.13422/j.cnki.syfjx.202202028.

HU Jinping,CHEN Liyun,YAN Shiyun.Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-κB/iNOS/NO Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(03):110-116. DOI： 10.13422/j.cnki.syfjx.202202028.

摘要

目的

探究生脉散加减对老年心肌梗死患者心功能的保护作用并探讨核转录因子-

B/诱导型一氧化氮合酶/一氧化氮（NF-

B/iNOS/NO）信号通路在其中的作用机制。

方法

前瞻性对2019年12月至2021年12月青海省中医院老年心肌梗死患者136例进行研究，按照随机数字表法分为观察组、对照组，各68例。对照组实施常规西药治疗，观察组实施常规西药+生脉散加减治疗，两组患者均给予经皮冠状动脉介入治疗进行血运重建。比较两组患者心功能相关指标，血清白细胞介素-6（IL-6）、肿瘤坏死因子-

（TNF-

）及基质金属蛋白酶-9（MMP-9）水平，超声心动图指标，心功能分级，NF-

B/iNOS/NO信号通路变化，氧化应激指标变化及不良心血管事件（MACE）发生情况。

结果

与本组治疗前比较，两组患者的N末端B型利钠肽原（NT-pro BNP）、血清炎症指标、左室收缩末期容积（LVESV）、左室舒张末期容积（LVEDV）、NO、iNOS、NF-

B p65及丙二醛（MDA）水平均明显降低（

0.05，

0.01），左室射血分数（LVEF）及超氧化物歧化酶（SOD）均明显升高（

0.05）。治疗后与对照组比较，观察组NT-pro BNP、血清炎症指标、LVESV、LVEDV、NO、iNOS、NF-

B p65及MDA水平均明显降低（

0.05），LVEF及SOD均明显升高（

0.05）。两组患者纽约心脏病协会（NYHA）心功能分级比较差异无统计学意义。观察组MACE发生率明显低于对照组（

0.05）。

结论

生脉散加减可明显降低老年心肌梗死患者NT-pro BNP、血清炎症指标水平，改善超声心动图指标，可调控NF-

B/iNOS/NO信号通路变化及降低氧化应激指标，减少不良心血管事件发生率，具有较好的心功能保护作用。

Abstract

Objective

To explore the protective effect of modified Shengmaisan on cardiac function in elderly patients with myocardial infarction based on the nuclear factor-

B/induction nitric oxide synthase/nitric oxide （NF-

B/iNOS/NO） signaling pathway.

Method

A total of 136 elderly patients with myocardial infarction treated in Qinghai Hospital of Traditional Chinese Medicine from december 2019 to december 2021 were included. They were randomly divided into an observation group and a control group， with 68 cases in each group. The control group was treated with conventional western medicine， and the observation group was treated with conventional western medicine + modified Shengmaisan. Both groups were treated with percutaneous coronary intervention for revascularization. The indexes related to cardiac function and levels of serum interleukin-6 （IL-6）， tumor necrosis factor-

（TNF-

）， and matrix metalloproteinase-9 （MMP-9）

were analyzed and compared between the two groups. The echocardiographic index， cardiac function classification， changes in the NF-

B/iNOS/NO signaling pathway， oxidative stress indexes， and major adverse cardiovascular events （MACE） of the two groups were compared.

Result

Compared with those before treatment， the levels of N-terminal B-type natriuretic peptide （NT-pro BNP）， serum inflammatory indexes， left ventricular end systolic volume （LVESV）， left ventricular end diastolic volume （LVEDV）， NO， iNOS， NF-

B p65， and methane dicarboxylic aldehyde （MDA） were significantly reduced （

0.05，

0.01）， and the left ventricular ejection fraction （LVEF） and superoxide dismutase (SOD） were significantly increased （

0.05）. After treatment， as compared with the control group， the levels of NT-pro BNP， serum inflammatory indexes， LVESV， LVEDV， NO， iNOS， NF-

B p65， and MDA in the observation group were significantly reduced （

0.05）， and those of LVEF and SOD were significantly increased （

0.05）. There was no significant difference in the New York Heart Association (NYHA) cardiac function classification between two groups. The incidence of MACE in the observation group was significantly lower than that in the control group （

0.05）.

Conclusion

Modified Shengmaisan can significantly reduce NT-pro BNP and levels of serum inflammatory indexes in elderly patients with myocardial infarction， improve echocardiographic indexes， regulate the NF-

B/iNOS/NO signaling pathway， and reduce the oxidative stress index and the incidence of MACE， which has a good protective effect on cardiac function.

关键词

Keywords

references

张占帅，秦少强，王亚玲，等．急性心肌梗死患者血清人软骨糖蛋白39，可溶性肿瘤坏死因子受体1水平与心功能及预后的相关性［J］．中国动脉硬化杂志， 2022 ， 30 （ 3 ）： 243 - 259 ．

DAI Y ， CHEN Y ， WEI G ， et al . Ivabradine protects rats against myocardial infarction through reinforcing autophagy via inhibiting PI3K/Akt/mTOR/p70S6K pathway ［J］. Bioengineered ， 2021 ， 12 （ 1 ）： 1826 - 1837 .

XIE Y ， WANG Y ， ZHAO L ， et al . Identification of potential biomarkers and immune cell infiltration in acute myocardial infarction（AMI）using bioinformatics strategy ［J］. Bioengineered ， 2021 ， 12 （ 1 ）： 24022 - 24023 .

GUAN G ， HUO D ， LI Y ， et al . Engineering hiPSC-CM and hiPSC-EC laden 3D nanofibrous splenic hydrogel for improving cardiac function through revascularization and remuscularization in infarcted heart ［J］. Bioact Mater ， 2021 ， 6 （ 12 ）： 4415 - 4429 .

张亚萍，游琛，韦玉娜，等．基于TGF- β 1 /Smads信号通路探讨当归芍药散对卵巢储备功能低下模型大鼠的影响［J］．中国实验方剂学杂志， 2021 ， 27 （ 21 ）： 47 - 54 ．

ZHI H ， ZHANG Z ， DENG Y ， et al . Restoring perturbed oxylipins with Danqi Tongmai tablet attenuates acute myocardial infarction ［J］. Phytomedicine ， 2021 ， 90 （ 6 ）： 153616 - 153616 .

李媛．炙甘草汤和生脉散加减治疗小儿气阴亏虚型病毒性心肌炎的临床观察［J］．临床医学， 2021 ， 41 （ 2 ）： 110 - 113 ．

HAN M ， JEON J H ， JY S ， et al . Intramyocardial delivery of human cardiac stem cell spheroids with enhanced cell engraftment ability and cardiomyogenic potential for myocardial infarct repair ［J］. J Control Release ， 2021 ， 336 （ 10 ）： 499 - 509 .

吕佳誉，崔向宁，苏文革．基于网络药理学探讨生脉散治疗心律失常作用机制［J］．中医学报， 2021 ， 36 （ 1 ）： 153 - 159 ．

中华医学会心血管病学分会，中华心血管病杂志编辑委员会，《中国循环杂志》编辑委员会 . 急性心肌梗死诊断和治疗指南［J］. 中华心血管病杂志， 2001 ， 29 （ 12 ）： 710 - 725 .

陈可冀，史大卓 . 冠心病及急性心肌梗死中医临床辨证标准及防治指南［M］. 北京：人民卫生出版社， 2014 .

FANG Y ， DUAN C ， CHEN S ， et al . Tanshinone-Ⅱ A inhibits myocardial infarct via decreasing of the mitochondrial apoptotic signaling pathway in myocardiocytes ［J］. Int J Mol Med ， 2021 ， 48 （ 2 ）： 1 - 11 .

杨君，孙静，吴紫阳，等．银翘散合生脉散加减治疗热毒侵心型病毒性心肌炎临床疗效观察［J］．中医药学报， 2021 ， 49 （ 2 ）： 52 - 57 ．

ÖZTÜRK R ， İNAN D ， GÜNGÖR B . Systemic Immune-inflammation index is a predictor of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction ［J］. Angiology ， 2021 ， 11 （ 7 ）： 3319 - 3321 .

赵正耀，杨传华，杨洁．生脉散加减治疗扩张型心肌病的经验总结［J］．中西医结合心脑血管病杂志， 2020 ， 18 （ 22 ）： 3902 - 3904 ．

马涛，谭雨晴，陈恒文，等．生脉散联合常规西药治疗病毒性心肌炎疗效及安全性的Meta分析［J］．北京中医药， 2020 ， 39 （ 7 ）： 725 - 730 ．

曹占鸿，潘建衡，李娜，等．生脉散现代药理作用及作用机制的研究进展［J］．中国实验方剂学杂志， 2019 ， 25 （ 22 ）： 212 - 218 ．

杜爱玲，刘晨辉，宋吉哲，等．心悦胶囊对PCI后AMI患者心功能的影响及可能机制［J］．山东医药， 2020 ， 60 （ 4 ）： 17 - 21 ．

王兴，侯平．生脉散加减治疗慢性心力衰竭气阴两虚证疗效及安全性的Meta分析［J］．云南中医中药杂志， 2019 ， 40 （ 11 ）： 91 - 93 ．

李海玲，吴怀庭，苏建英，等．生脉散加减联合吡格列酮治疗2型糖尿病合并冠心病心绞痛疗效观察［J］．实用中医药杂志， 2018 ， 34 （ 6 ）： 673 - 674 ．

张桂艳，胡建国．生脉散加减治疗病毒性心肌炎（心悸）的临床效果［J］．世界最新医学信息文摘， 2018 ， 18 （ 58 ）： 204 - 205 ．

崔洁，于远望．生脉散防治心血管疾病的研究进展［J］．现代中医药， 2018 ， 38 （ 3 ）： 78 - 81 ．

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical Efficacy of Early Application of Da Xianxiongtang in Mitigating Progression of Acute Pancreatitis

Efficacy of Shexiang Tongxin Dropping Pills in Treatment of Coronary Slow Flow and Its Effect on Inflammatory Factors

Effect of Zishen Tongguan Formula on "Gut-prostate" Axis of Rats with Chronic Non-bacterial Prostatitis Based on 16S rDNA Sequencing

Effect of Rhei Radix et Rhizoma Before and After Steaming with Wine on Intestinal Flora and Immune Environment in Constipation Model Mice

Exploring Mechanism of Different Processed Products of Baiyaojian and Its Formula in Treating Ulcerative Colitis Based on Serum Metabolomics and Flow Cytometry

Related Author

REN Dongsheng

TAN Judan

LIAO Haitang

LIU Qinghai

WENG Xiangwen

GUO Wenhui

WANG Yiyan

ZHOU Yuling

Related Institution

Chengdu University of Traditional Chinese Medicine（TCM）

Chongqing TCM Hospital

Hospital of Chengdu University of TCM

Dongzhimen Hospital， Beijing University of Chinese Medicine

Jiangsu Engineering Research Centre for Innovative Chinese Medicine Preparations， Jiangsu Integration Innovation Centre for Specialty Chinese Medicine Preparations，Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰

Protective Effect of Modified Shengmaisan on Cardiac Function in Elderly Patients with Myocardial Infarction Based on NF-κB/iNOS/NO Signaling Pathway

DOI：10.13422/j.cnki.syfjx.202202028

摘要

Abstract

关键词

Keywords

references